Furthermore, recent progress in nanotherapeutics has shown the ability of nanoparticles to bypass ABC transporters when delivering anticancer drugs to tumor cells, providing a new strategy to overcome chemoresistance of CSCs [73]. The gene discussed is ABCG2; the disease is neoplasm.